Mostrar el registro sencillo del ítem
Potential clinical use of azithromycin against gastroenteritis-causing pathogens other than Campylobacter
dc.contributor.author | Casanovas-Moreno-Torres, Isabel | |
dc.contributor.author | Gutiérrez-Soto, Blanca | |
dc.contributor.author | Diana Modovan, Teodora | |
dc.contributor.author | Expósito Ruiz, Manuela | |
dc.contributor.author | Navarro-Marí, José María | |
dc.contributor.author | Gutiérrez Fernández, José | |
dc.date.accessioned | 2024-05-08T07:43:13Z | |
dc.date.available | 2024-05-08T07:43:13Z | |
dc.date.issued | 2020-10 | |
dc.identifier.citation | Casanovas-Moreno-Torres I, Gutiérrez-Soto B, Modovan TD, Expósito-Ruiz M, Navarro-Marí JM, Gutiérrez-Fernández J. Potential clinical use of azithromycin against gastroenteritis-causing pathogens other than Campylobacter. New Microbiol. 2020 Oct;43(4):198-200 | es_ES |
dc.identifier.other | PMID: 33021318 | |
dc.identifier.uri | https://hdl.handle.net/10481/91518 | |
dc.description.abstract | The activity of azithromycin against enteritis-producing agents other than Campylobacter spp. was studied. The susceptibility to azithromycin, through gradient test, of 88 clinical isolates (51 Salmonella spp., 23 Aeromonas spp., 10 Shigella sonnei and 4 Yersinia enterocolitica) for one year was studied prospectively. The results were compared with the activity of ampicillin, trimethoprim-sulfamethoxazole and ciprofloxacin by microdilution. For azithromycin, the minimum inhibitory concentration (MIC) 50 and MIC90 were 4 and 12 mg/l, respectively. Six (6.8%) isolates were simultaneously resistant to ampicillin, trimethoprim- sulfamethoxazole and ciprofloxacin, and 3 (50%) of them presented a MIC >256 mg/l. Azithromycin may be a good empirical therapeutic option for the treatment of bacterial enteritis. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | New Microbiol | es_ES |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.title | Potential clinical use of azithromycin against gastroenteritis-causing pathogens other than Campylobacter | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es_ES |